Sino-Life Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Sino-Life Group şirketinin toplam hissedar öz sermayesi CN¥105.9M ve toplam borcu CN¥16.7M olup, bu da borç-öz sermaye oranını 15.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥262.1M ve CN¥156.1M dir.

Anahtar bilgiler

15.7%

Borç/özkaynak oranı

CN¥16.67m

Borç

Faiz karşılama oranı	n/a
Nakit	CN¥164.11m
Eşitlik	CN¥105.95m
Toplam yükümlülükler	CN¥156.11m
Toplam varlıklar	CN¥262.05m

Son finansal sağlık güncellemeleri

Does Sino-Life Group (HKG:8296) Have A Healthy Balance Sheet?

Jun 15

Recent updates

Revenues Not Telling The Story For Sino-Life Group Limited (HKG:8296) After Shares Rise 32%

Aug 07

There's Reason For Concern Over Sino-Life Group Limited's (HKG:8296) Massive 25% Price Jump

May 31

Lacklustre Performance Is Driving Sino-Life Group Limited's (HKG:8296) 29% Price Drop

Apr 16

Getting In Cheap On Sino-Life Group Limited (HKG:8296) Is Unlikely

Jan 25

Sino-Life Group (HKG:8296) Is Looking To Continue Growing Its Returns On Capital

Oct 20

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 8296 'nin kısa vadeli varlıkları ( CN¥208.1M ) kısa vadeli yükümlülüklerini ( CN¥128.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: 8296 şirketinin kısa vadeli varlıkları ( CN¥208.1M ) uzun vadeli yükümlülüklerini ( CN¥27.4M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 8296 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 8296 şirketinin borç/öz sermaye oranı son 5 yılda 8.3% seviyesinden 15.7% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 8296 şirketinin mevcut serbest nakit akışına göre 3 yıldan fazla bir süre için yeterli nakit pistine sahip olduğu belirtiliyor.

Tahmini Nakit Akışı: 8296, serbest nakit akışı her yıl % 19.3 oranında tarihi oranda azalmaya devam ederse 3 yıldan fazla bir süre yeterli nakit akışına sahip olur

Sino-Life Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Does Sino-Life Group (HKG:8296) Have A Healthy Balance Sheet?

Recent updates

First half 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.005 loss in 1H 2023)

Sino-Life Group Limited to Report First Half, 2024 Results on Aug 29, 2024

Revenues Not Telling The Story For Sino-Life Group Limited (HKG:8296) After Shares Rise 32%

There's Reason For Concern Over Sino-Life Group Limited's (HKG:8296) Massive 25% Price Jump

New minor risk - Share price stability

Lacklustre Performance Is Driving Sino-Life Group Limited's (HKG:8296) 29% Price Drop

Full year 2023 earnings released: CN¥0.009 loss per share (vs CN¥0.001 loss in FY 2022)

Sino-Life Group Limited, Annual General Meeting, Jun 21, 2024

Sino-Life Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

Getting In Cheap On Sino-Life Group Limited (HKG:8296) Is Unlikely

New major risk - Market cap size

Third quarter 2023 earnings released: CN¥0.003 loss per share (vs CN¥0.002 profit in 3Q 2022)

Sino-Life Group Limited to Report Q3, 2023 Results on Nov 08, 2023

Sino-Life Group (HKG:8296) Is Looking To Continue Growing Its Returns On Capital

Sino-Life Group Limited Announces Resignation of XU Qiang resigned as an Executive Director

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CN¥0.008 loss per share (vs CN¥0.01 loss in 2Q 2022)

Now 21% undervalued

Sino-Life Group Limited to Report First Half, 2023 Results on Aug 07, 2023

Investors Will Want Sino-Life Group's (HKG:8296) Growth In ROCE To Persist

Sino-Life Group Limited Announces Board Changes

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.002 (vs CN¥0.001 in 3Q 2021)

Sino-Life Group Limited to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: CN¥0.009 loss per share (vs CN¥0 in 2Q 2021)

Sino-Life Group Limited to Report First Half, 2022 Results on Aug 12, 2022

Does Sino-Life Group (HKG:8296) Have A Healthy Balance Sheet?

First quarter 2022 earnings released: EPS: CN¥0.001 (vs CN¥0.004 in 1Q 2021)

Sino-Life Group Limited to Report Q1, 2022 Results on May 13, 2022

Sino-Life Group Limited, Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CN¥0.004 loss per share (vs CN¥0.004 loss in FY 2020)

Sino-Life Group Limited Announces Executive Changes

Returns Are Gaining Momentum At Sino-Life Group (HKG:8296)

Third quarter 2021 earnings released: EPS CN¥0.001 (vs CN¥0.003 in 3Q 2020)

Sino-Life Group's (HKG:8296) Returns On Capital Are Heading Higher

First quarter 2021 earnings released: EPS CN¥0.004 (vs CN¥0.003 loss in 1Q 2020)

Returns At Sino-Life Group (HKG:8296) Are On The Way Up

Full year 2020 earnings released: CN¥0.005 loss per share (vs CN¥0.005 loss in FY 2019)

Sino-Life Group Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Sino-Life Group Limited Announces Re-designation of XU Qiang from the Non-Executive Director to an Executive Director

Third quarter 2020 earnings released: EPS CN¥0.003

Third quarter 2020 earnings released: EPS CN¥0.003

Sino-Life Group Limited to Report Q3, 2020 Results on Nov 13, 2020

First half earnings released

First half earnings released

Sino-Life Group Limited to Report First Half, 2020 Results on Aug 14, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin